AVITA Medical, Inc.
RCEL
$7.19
-$0.325-4.33%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.80% | -70.25% | -63.13% | -69.63% | -32.69% |
| Total Depreciation and Amortization | 78.16% | 57.22% | 38.07% | 29.63% | 11.27% |
| Total Amortization of Deferred Charges | -- | -74.71% | -49.56% | -24.26% | 0.89% |
| Total Other Non-Cash Items | 453.95% | 0.86% | -39.82% | -54.72% | -62.23% |
| Change in Net Operating Assets | 28.84% | 37.60% | -282.30% | -779.78% | -449.67% |
| Cash from Operations | -28.75% | -69.11% | -119.30% | -165.00% | -99.11% |
| Capital Expenditure | -564.08% | -580.09% | -507.27% | -233.93% | -205.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,457.36% | -125.58% | -113.05% | -99.43% | 115.83% |
| Cash from Investing | 2,225.02% | -140.20% | -131.35% | -109.58% | 108.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 117.62% | 71.48% | 121.60% | 93.64% | 79.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.31% | 2,176.97% | 3,245.04% | 3,716.26% | 4,386.00% |
| Foreign Exchange rate Adjustments | -- | -103.45% | -165.52% | 10.53% | 38.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.05% | -219.14% | -886.84% | -357.28% | 110.53% |
